This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Interstitial Cell-Stimulating Hormone

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Interstitial Cell-Stimulating Hormone Means

Interstitial Cell-Stimulating Hormone is another name for luteinizing hormone (LH) or lutropin. It is a hormone made by the pituitary gland, a small gland at the base of the brain. This hormone plays a key role in the reproductive system. In females, it helps the ovaries release eggs during the menstrual cycle and supports the production of hormones that prepare the uterus for a fertilized egg. In males, it acts on the testes to stimulate cells to grow and produce testosterone, the hormone responsible for male sexual development and fertility.

Why It Can Matter in Cancer Care

Hormones like LH can be important in cancer care because some cancers, such as prostate cancer, depend on hormones like testosterone to grow. Since LH helps control testosterone production in men, treatments may target this hormone or its effects to slow cancer growth. For example, some hormone therapies work by lowering LH levels or blocking its action to reduce testosterone. Understanding LH’s role can help patients grasp why certain hormone treatments are used and how they affect the body.

Where Patients Might See or Hear This Term

Patients might encounter the term Interstitial Cell-Stimulating Hormone or its other names (LH, luteinizing hormone, lutropin) in lab test results, medical reports, treatment plans, or discussions about hormone therapies. It may also come up when doctors explain how hormone levels affect cancer or fertility. Because the hormone has several names, it’s helpful to ask the care team to clarify what it means in the specific context of the patient’s care.

What the Term Does Not Automatically Mean

Seeing the term Interstitial Cell-Stimulating Hormone or LH in a report does not by itself mean a diagnosis or treatment decision. It is simply the name of a hormone involved in reproductive and hormonal functions. Its presence or level needs to be interpreted by a healthcare provider in the context of other tests, symptoms, and the patient’s overall health. Patients should avoid assuming it signals a problem or a specific treatment without professional explanation.

Common Confusions and How to Ask Questions

Because this hormone has several names, patients and caregivers may get confused when they see different terms like LH, luteinizing hormone, or lutropin. It’s helpful to ask the care team to explain which hormone is being discussed and what it means for the patient’s health or treatment. Questions like “What does this hormone level mean for my cancer or treatment?” or “How does this hormone affect my body?” can guide useful conversations.

Reading the Term in Context

Always consider Interstitial Cell-Stimulating Hormone or LH as part of a bigger picture. It is one piece of information among many in medical reports or treatment plans. Understanding its role helps patients and caregivers better follow discussions about hormone-related treatments or side effects. If unsure, the best step is to ask the healthcare team how this hormone relates to the patient’s specific condition and care plan.

Safety and Next Steps

This information is meant to educate and does not replace medical advice. It cannot determine what is safe or appropriate for any individual. If you see this term in your medical records or hear it during visits, the safest next step is to ask your care team to explain what it means for you personally. They can help you understand how it fits into your diagnosis, treatment, or monitoring and what questions you might want to ask next.

Sources

Public source information used for this glossary entry includes: